Dr Aaron Shingo Kusano, MD | |
2841 Debarr Rd Ste 100, Anchorage, AK 99508-2945 | |
(907) 276-2400 | |
(907) 276-4888 |
Full Name | Dr Aaron Shingo Kusano |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 14 Years |
Location | 2841 Debarr Rd Ste 100, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407170467 | NPI | - | NPPES |
1407170467 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | MD60973030 (Washington) | Secondary |
2085R0001X | Radiology - Radiation Oncology | 101033 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Alaska Regional Hospital | Anchorage, AK | Hospital |
Providence Alaska Medical Center | Anchorage, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alaska Radiation Oncology Specialists, Inc | 9931391687 | 4 |
Valley Radiation Oncology | 5395937064 | 4 |
News Archive
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such 'misfolding' and 'protein aggregation' processes damage cells and cause diseases such as Alzheimer's and type 2 diabetes. A team of scientists from the Technical University of Munich headed by Professor Aphrodite Kapurniotu have now developed molecules that suppress protein aggregation and could pave the way for new treatments to combat Alzheimer's, type 2 diabetes and other cell-degenerative diseases.
Today's health policy headlines focus on President Obama's Tuesday meeting with health insurance executives and the administration's new version of the "Patient's Bill of Rights."
Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.
› Verified 8 days ago
Entity Name | Alaska Radiation Oncology Specialists, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437257979 PECOS PAC ID: 9931391687 Enrollment ID: O20101013000294 |
News Archive
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such 'misfolding' and 'protein aggregation' processes damage cells and cause diseases such as Alzheimer's and type 2 diabetes. A team of scientists from the Technical University of Munich headed by Professor Aphrodite Kapurniotu have now developed molecules that suppress protein aggregation and could pave the way for new treatments to combat Alzheimer's, type 2 diabetes and other cell-degenerative diseases.
Today's health policy headlines focus on President Obama's Tuesday meeting with health insurance executives and the administration's new version of the "Patient's Bill of Rights."
Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.
› Verified 8 days ago
Entity Name | Valley Radiation Oncology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447570874 PECOS PAC ID: 5395937064 Enrollment ID: O20101013000566 |
News Archive
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such 'misfolding' and 'protein aggregation' processes damage cells and cause diseases such as Alzheimer's and type 2 diabetes. A team of scientists from the Technical University of Munich headed by Professor Aphrodite Kapurniotu have now developed molecules that suppress protein aggregation and could pave the way for new treatments to combat Alzheimer's, type 2 diabetes and other cell-degenerative diseases.
Today's health policy headlines focus on President Obama's Tuesday meeting with health insurance executives and the administration's new version of the "Patient's Bill of Rights."
Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Aaron Shingo Kusano, MD 2841 Debarr Rd Ste 100, Anchorage, AK 99508-2945 Ph: (907) 276-2400 | Dr Aaron Shingo Kusano, MD 2841 Debarr Rd Ste 100, Anchorage, AK 99508-2945 Ph: (907) 276-2400 |
News Archive
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such 'misfolding' and 'protein aggregation' processes damage cells and cause diseases such as Alzheimer's and type 2 diabetes. A team of scientists from the Technical University of Munich headed by Professor Aphrodite Kapurniotu have now developed molecules that suppress protein aggregation and could pave the way for new treatments to combat Alzheimer's, type 2 diabetes and other cell-degenerative diseases.
Today's health policy headlines focus on President Obama's Tuesday meeting with health insurance executives and the administration's new version of the "Patient's Bill of Rights."
Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.
› Verified 8 days ago
Michael James Mcdonnell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
William Patton Perry, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2751 Debarr Rd Ste B360, Anchorage, AK 99508 Phone: 907-792-7920 | |
Burl C Stephens, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 | |
Dr. Matthew Raymond Minor, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3650 Piper St Ste A, Anchorage, AK 99508 Phone: 907-339-9455 Fax: 907-339-9445 | |
Dr. Gerald Edward York Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3650 Piper Street Suite A, Anchorage, AK 99508 Phone: 907-222-4624 Fax: 907-222-4651 | |
John Mccormick, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2110 E Northern Lights Blvd, Anchorage, AK 99508 Phone: 907-563-3700 Fax: 907-563-3740 | |
Dr. Wandal Bryan Winn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-339-9455 Fax: 907-339-9445 |